GATA5 interacts with GATA4 and GATA6 in outflow tract development

Developmental Biology

Volumn 358, Issue 2, 2011, Pages 368-378

  Laforest, Brigitte ^a   Nemer, Mona ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Congenital heart disease; Double outlet right ventricle; Endocardial cushion; Heart development; Septal defects; Transcription factors

Indexed keywords

CELL PROTEIN; MYOCYTE ENHANCER FACTOR 2C; PROTEIN HAND2; PROTEIN HEY1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 5; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR TBX20; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; CELL DIFFERENTIATION; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; ENDOCARDIAL CUSHION; ENDOCARDIUM; GENE EXPRESSION; GENE INTERACTION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HETEROZYGOTE; HISTOPATHOLOGY; MITRAL VALVE HYPERTROPHY; MOUSE; MUTANT; NONHUMAN; OUTFLOW TRACT DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE HYPERTROPHY;

MUS;

EID: 80053118299     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2011.07.037     Document Type: Article

References (65)

1. Aries A., Paradis P., Lefebvre C., Schwartz R.J., Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6975-6980.
2. Bajolle F., Zaffran S., Meilhac S.M., Dandonneau M., Chang T., Kelly R.G., Buckingham M.E. Myocardium at the base of the aorta and pulmonary trunk is prefigured in the outflow tract of the heart and in subdomains of the second heart field. Dev. Biol. 2008, 313:25-34.
3. Basson C.T., Bachinsky D.R., Lin R.C., Levi T., Elkins J.A., Soults J., Grayzel D., Kroumpouzou E., Traill T.A., Leblanc-Straceski J., Renault B., Kucherlapati R., Seidman J.G., Seidman C.E. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 1997, 15:30-35.
4. Biben C., Weber R., Kesteven S., Stanley E., McDonald L., Elliott D.A., Barnett L., Koentgen F., Robb L., Feneley M., Harvey R.P. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ. Res. 2000, 87:888-895.
5. Bruneau B.G., Nemer G., Schmitt J.P., Charron F., Robitaille L., Caron S., Conner D.A., Gessler M., Nemer M., Seidman C.E., Seidman J.G. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001, 106:709-721.
6. Buckingham M., Meilhac S., Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 2005, 6:826-835.
7. Charron F., Paradis P., Bronchain O., Nemer G., Nemer M. Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol. Cell. Biol. 1999, 19:4355-4365.
8. Crispino J.D., Lodish M.B., Thurberg B.L., Litovsky S.H., Collins T., Molkentin J.D., Orkin S.H. Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev. 2001, 15:839-844.
9. Dodou E., Verzi M.P., Anderson J.P., Xu S.M., Black B.L. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
10. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., Rothrock C.R., Eapen R.S., Hirayama-Yamada K., Joo K., Matsuoka R., Cohen J.C., Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
11. Gill H.K., Splitt M., Sharland G.K., Simpson J.M. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J. Am. Coll. Cardiol. 2003, 42:923-929.
12. Goldmuntz E., Geiger E., Benson D.W. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation 2001, 104:2565-2568.
13. Grepin C., Dagnino L., Robitaille L., Haberstroh L., Antakly T., Nemer M. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol. Cell. Biol. 1994, 14:3115-3129.
14. Grepin C., Nemer G., Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 1997, 124:2387-2395.
15. High F.A., Jain R., Stoller J.Z., Antonucci N.B., Lu M.M., Loomes K.M., Kaestner K.H., Pear W.S., Epstein J.A. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J. Clin. Invest. 2009, 119:1986-1996.
16. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002, 39:1890-1900.
17. Holler K.L., Hendershot T.J., Troy S.E., Vincentz J.W., Firulli A.B., Howard M.J. Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expression and outflow tract development. Dev. Biol. 2010, 341:291-304.
18. Hutson M.R., Kirby M.L. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin. Cell Dev. Biol. 2007, 18:101-110.
19. Insley J. The heritability of congenital heart disease. Br. Med. J. (Clin. Res. Ed.) 1987, 294:662-663.
20. Kelly R.G., Brown N.A., Buckingham M.E. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 2001, 1:435-440.
21. Kodo K., Nishizawa T., Furutani M., Arai S., Yamamura E., Joo K., Takahashi T., Matsuoka R., Yamagishi H. GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13933-13938.
22. Koutsourakis M., Langeveld A., Patient R., Beddington R., Grosveld F. The transcription factor GATA6 is essential for early extraembryonic development. Development 1999, 126:723-732.
23. Kuo C.T., Morrisey E.E., Anandappa R., Sigrist K., Lu M.M., Parmacek M.S., Soudais C., Leiden J.M. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997, 11:1048-1060.
24. Laforest B., Andelfinger G., Nemer M. Loss of GATA5 in mice leads to bicuspid aortic valve. J. Clin. Invest. 2011, 121.
25. Lepore J.J., Mericko P.A., Cheng L., Lu M.M., Morrisey E.E., Parmacek M.S. GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis. J. Clin. Invest. 2006, 116:929-939.
26. Li Q.Y., Newbury-Ecob R.A., Terrett J.A., Wilson D.I., Curtis A.R., Yi C.H., Gebuhr T., Bullen P.J., Robson S.C., Strachan T., Bonnet D., Lyonnet S., Young I.D., Raeburn J.A., Buckler A.J., Law D.J., Brook J.D. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet. 1997, 15:21-29.
27. Lien C.L., Wu C., Mercer B., Webb R., Richardson J.A., Olson E.N. Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development 1999, 126:75-84.
28. Lin S.C., Dolle P., Ryckebusch L., Noseda M., Zaffran S., Schneider M.D., Niederreither K. Endogenous retinoic acid regulates cardiac progenitor differentiation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9234-9239.
29. Lin X., Huo Z., Liu X., Zhang Y., Li L., Zhao H., Yan B., Liu Y., Yang Y., Chen Y.H. A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. J. Hum. Genet. 2010, 55(10):662-667.
30. Luna-Zurita L., Prados B., Grego-Bessa J., Luxan G., Del M.G., Benguria A., Adams R.H., Perez-Pomares J.M., de la Pompa J.L. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 2010, 120:3493-3507.
31. Maitra M., Koenig S.N., Srivastava D., Garg V. Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr. Res. 2010, 68(4):281-285.
32. McFadden D.G., Charité J., Richardson J.A., Srivastava D., Firulli A.B., Olson E.N. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 2000, 127:5331-5341.
33. Mjaatvedt C.H., Nakaoka T., Moreno-Rodriguez R., Norris R.A., Kern M.J., Eisenberg C.A., Turner D., Markwald R.R. The outflow tract of the heart is recruited from a novel heart-forming field. Dev. Biol. 2001, 238:97-109.
34. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6 - ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 2000, 275:38949-38952.
35. Molkentin J.D., Lin Q., Duncan S.A., Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997, 11:1061-1072.
36. Morikawa Y., Cserjesi P. Cardiac neural crest expression of Hand2 regulates outflow and second heart field development. Circ. Res. 2008, 103:1422-1429.
37. Nakajima Y., Morishima M., Nakazawa M., Momma K. Inhibition of outflow cushion mesenchyme formation in retinoic acid-induced complete transposition of the great arteries. Cardiovasc. Res. 1996, 31:E77-E85. (Spec No).
38. Nemer G., Nemer M. Cooperative interaction between GATA-5 and NF-ATc regulates endothelial-endocardial differentiation of cardiogenic cells. Development 2002, 129:4045-4055.
39. Nemer G., Nemer M. Transcriptional activation of BMP-4 and regulation of mammalian organogenesis by GATA-4 and -6. Dev. Biol. 2003, 254:131-148.
40. Nemer M., Nemer G. GATA Factors. Heart Development and Regeneration 2010, Academic Press. N. Rosenthal, R. Harvey (Eds.).
41. Nemer G., Fadlalah F., Usta J., Nemer M., Dbaibo G., Obeid M., Bitar F. A novel mutation in the GATA4 gene in patients with tetralogy of Fallot. Hum. Mutat. 2006, 27:293-294.
42. Patient R.K., McGhee J.D. The GATA family (vertebrates and invertebrates). Curr. Opin. Genet. Dev. 2002, 12:416-422.
43. Pehlivan T., Pober B.R., Brueckner M., Garrett S., Slaugh R., Van Rheeden R., Wilson D.B., Watson M.S., Hing A.V. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am. J. Med. Genet. 1999, 83:201-206.
44. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. Int. Rev. Cytol. 2005, 243:287-335.
45. Pierpont M.E., Basson C.T., Benson D.W., Gelb B.D., Giglia T.M., Goldmuntz E., McGee G., Sable C.A., Srivastava D., Webb C.L. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007, 115:3015-3038.
46. Pu W.T., Ishiwata T., Juraszek A.L., Ma Q., Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev. Biol. 2004, 275:235-244.
47. Qian L., Bodmer R. Partial loss of GATA factor Pannier impairs adult heart function in Drosophila. Hum. Mol. Genet. 2009, 18:3153-3163.
48. Rajagopal S.K., Ma Q., Obler D., Shen J., Manichaikul A., Tomita-Mitchell A., Boardman K., Briggs C., Garg V., Srivastava D., Goldmuntz E., Broman K.W., Benson D.W., Smoot L.B., Pu W.T. Spectrum of heart disease associated with murine and human GATA4 mutation. J. Mol. Cell. Cardiol. 2007, 43:677-685.
49. Reiter J.F., Alexander J., Rodaway A., Yelon D., Patient R., Holder N., Stainier D.Y. Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev. 1999, 13:2983-2995.
50. Rivera-Feliciano J., Lee K.H., Kong S.W., Rajagopal S., Ma Q., Springer Z., Izumo S., Tabin C.J., Pu W.T. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006, 133:3607-3618.
51. Rojas A., Kong S.W., Agarwal P., Gilliss B., Pu W.T., Black B.L. GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol. Cell. Biol. 2008, 28:5420-5431.
52. Rutenberg J.B., Fischer A., Jia H., Gessler M., Zhong T.P., Mercola M. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 2006, 133:4381-4390.
53. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., Maron B.J., Seidman C.E., Seidman J.G. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
54. Shelton E.L., Yutzey K.E. Twist1 function in endocardial cushion cell proliferation, migration, and differentiation during heart valve development. Dev. Biol. 2008, 317:282-295.
55. Singh M.K., Li Y., Li S., Cobb R.M., Zhou D., Lu M.M., Epstein J.A., Morrisey E.E., Gruber P.J. Gata4 and Gata5 cooperatively regulate cardiac myocyte proliferation in mice. J. Biol. Chem. 2010, 285:1765-1772.
56. Srivastava D., Thomas T., Lin Q., Kirby M.L., Brown D., Olson E.N. Regulation of cardiac mesodermal and neural crest development by the bhlh transcription factor, dhand. Nat. Genet. 1997, 16:154-160.
57. Takeuchi J.K., Mileikovskaia M., Koshiba-Takeuchi K., Heidt A.B., Mori A.D., Arruda E.P., Gertsenstein M., Georges R., Davidson L., Mo R., Hui C.C., Henkelman R.M., Nemer M., Black B.L., Nagy A., Bruneau B.G. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development 2005, 132:2463-2474.
58. Timmerman L.A., Grego-Bessa J., Raya A., Bertran E., Perez-Pomares J.M., Diez J., Aranda S., Palomo S., McCormick F., Izpisua-Belmonte J.C., de la Pompa J.L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
59. Waldo K.L., Kumiski D.H., Wallis K.T., Stadt H.A., Hutson M.R., Platt D.H., Kirby M.L. Conotruncal myocardium arises from a secondary heart field. Development 2001, 128:3179-3188.
60. Watt A.J., Battle M.A., Li J., Duncan S.A. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12573-12578.
61. Winston J.B., Erlich J.M., Green C.A., Aluko A., Kaiser K.A., Takematsu M., Barlow R.S., Sureka A.O., LaPage M.J., Janss L.L., Jay P.Y. Heterogeneity of genetic modifiers ensures normal cardiac development. Circulation 2010, 121:1313-1321.
62. Xin M., Davis C.A., Molkentin J.D., Lien C.L., Duncan S.A., Richardson J.A., Olson E.N. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11189-11194.
63. Zeisberg E.M., Ma Q., Juraszek A.L., Moses K., Schwartz R.J., Izumo S., Pu W.T. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J. Clin. Invest. 2005, 115:1522-1531.
64. Zhang W., Li X., Shen A., Jiao W., Guan X., Li Z. GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur. J. Med. Genet. 2008, 51:527-535.
65. Zhao R., Watt A.J., Battle M.A., Li J., Bondow B.J., Duncan S.A. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev. Biol. 2008, 317:614-619.